Clinical Trial Update: Study of GSK3511294 in Healthy Chinese Participants [Phase 1]

View source ↗

Summary

Phase 1 trial of GSK3511294 in healthy Chinese participants completed to evaluate safety and pharmacokinetics for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK3511294

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED